Rap2B promotes migration and invasion of human suprarenal epithelioma

Tumor Biology

Volumn 35, Issue 9, 2014, Pages 9387-9394

  Di, Jie Hui ^a   Qu, De Bao ^a   Lu, Zheng ^a   Li, Lian Tao ^a   Cheng, Qian ^a   Xin, Yong ^a   Zhang, Long Zhen ^a   Zhang, Yanping ^a,b   Zheng, Jun Nian ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Invasion; Migration; Rap2B; Suprarenal epithelioma; Tissue microarray

Indexed keywords

GELATINASE A; RAP PROTEIN; RAP2B PROTEIN; UNCLASSIFIED DRUG; RAP2B PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER TISSUE; CARCINOGENESIS; CELL ASSAY; CELL INVASION; CELL INVASION ASSAY; CELL MIGRATION; CELL MIGRATION ASSAY; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM TUMOR; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY EPITHELIUM; KIDNEY PARENCHYMA; KIDNEY TUMOR; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUPRARENAL EPITHELIOMA; TISSUE MICROARRAY; TUMOR CELL; WESTERN BLOTTING; ZYMOGRAPHY; CELL MOTION; GENETICS; KIDNEY CARCINOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR INVASION;

BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NEOPLASM INVASIVENESS; RAP GTP-BINDING PROTEINS; RNA INTERFERENCE; TISSUE ARRAY ANALYSIS;

EID: 84919834385     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2174-8     Document Type: Article

References (24)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29. doi:10.3322/caac.20138.
2. Mohammed A, Shergill I, Little B. Management of metastatic renal cell carcinoma: current trends. Expert Rev Mol Diagn. 2009;9(1):75–83. doi:10.1586/14737159.9.1.75.
3. Kausch I, Jiang H, Ewerdwalbesloh N, Doehn C, Kruger S, Sczakiel G, et al. Inhibition of Ki-67 in a renal cell carcinoma severe combined immunodeficiency disease mouse model is associated with induction of apoptosis and tumour growth inhibition. BJU Int. 2005;95(3):416–20. doi:10.1111/j.1464-410X.2005.05312.x.
4. Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin N Am. 2003;30(4):843–52.
5. Ohmstede CA, Farrell FX, Reep BR, Clemetson KJ, Lapetina EG. RAP2B: a RAS-related GTP-binding protein from platelets. Proc Natl Acad Sci U S A. 1990;87(17):6527–31.
6. Farrell FX, Ohmstede CA, Reep BR, Lapetina EG. cDNA sequence of a new Ras-related gene (Rap2B) isolated from human platelets with sequence homology to rap2. Nucleic Acids Res. 1990;18(14):4281.
7. Zhang X, He Y, Lee KH, Dubois W, Li Z, Wu X, et al. Rap2B, a novel p53 target, regulates p53-mediated pro-survival function. Cell Cycle. 2013;12(8):1279–91. doi:10.4161/cc.24364. Georgetown, Tex.
8. Jin TG, Satoh T, Liao Y, Song C, Gao X, Kariya K, et al. Role of the CDC25 homology domain of phospholipase C epsilon in amplification of Rap1-dependent signaling. J Biol Chem. 2001;276(32):30301–7. doi:10.1074/jbc.M103530200.
9. Kelley GG, Reks SE, Ondrako JM, Smrcka AV. Phospholipase C(epsilon): a novel Ras effector. EMBO J. 2001;20(4):743–54. doi:10.1093/emboj/20.4.743.
10. Kelley GG, Reks SE, Smrcka AV. Hormonal regulation of phospholipase C epsilon through distinct and overlapping pathways involving G12 and Ras family G-proteins. Biochem J. 2004;378(Pt 1):129–39. doi:10.1042/bj20031370.
11. Song C, Hu CD, Masago M, Kariyai K, Yamawaki-Kataoka Y, Shibatohge M, et al. Regulation of a novel human phospholipase C, PLC epsilon, through membrane targeting by Ras. J Biol Chem. 2001;276(4):2752–7. doi:10.1074/jbc.M008324200.
12. Song C, Satoh T, Edamatsu H, Wu D, Tadano M, Gao X, et al. Differential roles of Ras and Rap1 in growth factor-dependent activation of phospholipase C epsilon. Oncogene. 2002;21(53):8105–13. doi:10.1038/sj.onc.1206003.
13. Bourguignon LY, Gilad E, Brightman A, Diedrich F, Singleton P. Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. J Biol Chem. 2006;281(20):14026–40. doi:10.1074/jbc.M507734200.
14. Bai J, Mei PJ, Liu H, Li C, Li W, Wu YP, et al. BRG1 expression is increased in human glioma and controls glioma cell proliferation, migration and invasion in vitro. J Cancer Res Clin Oncol. 2012;138(6):991–8. doi:10.1007/s00432-012-1172-8.
15. Hannon GJ. RNA interference. Nature. 2002;418(6894):244–51. doi:10.1038/418244a.
16. Elbashir SM, Harborth J, Weber K, Tuschl T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods. 2002;26(2):199–213. doi:10.1016/s1046-2023(02)00023-3. San Diego, Calif.
17. Torti M, Lapetina EG. Structure and function of rap proteins in human platelets. Thromb Haemost. 1994;71(5):533–43.
18. Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med. 2005;9(2):267–85.
19. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006;25(1):9–34. doi:10.1007/s10555-006-7886-9.
20. Badiga AV, Chetty C, Kesanakurti D, Are D, Gujrati M, Klopfenstein JD, et al. MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells. PLoS One. 2011;6(6):e20614. doi:10.1371/journal.pone.0020614.
21. Overall CM, Kleifeld O. Tumour microenvironment—opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer. 2006;6(3):227–39. doi:10.1038/nrc1821.
22. Jung CH, Kim EM, Park JK, Hwang SG, Moon SK, Kim WJ, et al. Bmal1 suppresses cancer cell invasion by blocking the phosphoinositide 3-kinase-Akt-MMP-2 signaling pathway. Oncol Rep. 2013;29(6):2109–13. doi:10.3892/or.2013.2381.
23. Lu CY, Lai SC. Induction of matrix metalloproteinase-2 and −9 via Erk1/2-NF-κB pathway in human astroglia infected with Toxoplasma gondii. Acta Trop. 2013;127(1):14–20. doi:10.1016/j.actatropica.2013.03.004.
24. Bae IH, Park MJ, Yoon SH, Kang SW, Lee SS, Choi KM, et al. Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1. Cancer Res. 2006;66:4991–5.